Parse Biosciences and Bit.bio announced a collaboration to build a transcription factor-driven cell identity map covering cell state and cell fate. The partners will combine Bit.bio’s Opti-ox programming technology and Cell Foundry platform with Parse’s Evercode scalable single-cell assay to test thousands of genetic variables alongside cell behavior.